Stephanie Singer


Singer, Stephanie

Stephanie Singer provides practical legal and business advice to entrepreneurs, startups and high-growth companies throughout their lifecycle. She represents a wide range of technology and life sciences companies on formation, equity-related matters, corporate governance, venture capital financings, mergers and acquisitions, and ongoing corporate matters. In addition, she represents venture capital funds in making portfolio investments. Ms. Singer also has considerable experience with public offerings, public company counseling and fund formation. Prior to joining WilmerHale, Ms. Singer worked at Highland Capital Partners and at Entrepreneur magazine.

Learn more about Ms. Singer's practice and how she can support your startup on

Recent Highlights

  • Represented Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, in its Series A financing
  • Represented Aquinnah Pharmaceuticals, a biotechnology company focused on RNA binding proteins for neurodegenerative diseases, in a $15 million investment
  • Represented Reflexis, a leader in retail real-time execution and workforce management solutions, in a minority equity investment
  • Represented SyncOnSet Technologies, a leading entertainment technology company digitizing physical production and managing creative content, in its $1.5 million Series A financing
  • Represented Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services, in its $6.14 million Series C financing
  • Represented Syros Pharmaceuticals, a life sciences company, in its IPO
  • Represented Accion Systems, a space technology startup led by MIT graduates, in its $7.5 million Series A funding
  • Represented Acacia Communications, a leading provider of high-speed coherent optical interconnect products, in its IPO

Publications & News


February 28, 2018

WilmerHale Represents Generation Bio in $100M Series B Financing

Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, recently announced the closing of a $100 million Series B financing.

January 19, 2018

WilmerHale Represents Pandion Therapeutics in $58M Series A Financing

On January 18, 2018, Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation, announced its $58 million Series A financing.

October 30, 2017

WilmerHale Represents Consumer Physics in $4.95M Series C Funding

Consumer Physics—developer of SCiO, the world's first pocket-sized connected micro-spectrometer—completed its Series C financing round raising a total of $4.95 million.

October 19, 2017

WilmerHale Reps Cydan in Raising $34M to Accelerate New Treatments for Rare Genetic Diseases

Cydan, the first orphan drug accelerator dedicated to advancing therapies that improve the lives of patients with rare genetic diseases, announced a new round of financing, raising a committed total of $34 million to advance the company's efforts to create new and innovative therapies for patients living with rare genetic diseases.

October 5, 2017

WilmerHale Reps Disarm Therapeutics in $30M Series A Financing

Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, announced the recent completion of a $30 million Series A financing.

October 3, 2017

WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine

Suono Bio, a company developing a platform technology designed to enable ultra-rapid delivery of therapeutics—including proteins and nucleic acids—to the gastrointestinal tract, has announced that it has raised its seed funding round from Polaris, MIT's “The Engine” and other investors.

May 18, 2017

Changing Lives One Small Step at a Time

Lawyers Clearinghouse details Jonathan Wolfman and Stephanie Singer's work for One Can Help, a nonprofit that provides resources for Massachusetts' neediest children and parents involved in the juvenile court system. Wolfman and Singer helped create the infrastructure needed to handle more One Can Help employees and answered questions about board structuring, governance and tax implications.

May 10, 2017

WilmerHale Represents Fulcrum Therapeutics in Series A Financing from GV

Fulcrum Therapeutics announced that it has secured additional Series A funding from GV (formerly Google Ventures) to support the continued advancement of its lead programs in Fragile X syndrome and Fascioscapularhumeral muscular dystrophy.

April 25, 2017

WilmerHale Counsels Aquinnah Pharmaceuticals in $10M Investment From Pfizer and AbbVie

Aquinnah Pharmaceuticals announced that Pfizer Inc. and AbbVie Inc. have invested in their work to treat Amyotrophic Lateral Sclerosis, Alzheimer's disease and other neurodegenerative diseases.

April 5, 2017

WilmerHale Counsels Reflexis to Accelerate Growth With Investment From Great Hill Partners

Reflexis, the leader in retail real-time execution and workforce management solutions, announced that it has received a minority equity investment from Great Hill Partners.

Speaking Engagements

Pro Bono

Ms. Singer's pro bono practices focuses primarily on nonprofit organizations. Ms. Singer has assisted multiple charitable organizations in obtaining 501(c)(3) status from the IRS, and she assists nonprofits with ongoing compliance and corporate governance matters. Ms. Singer also assists organizations who have lost their 501(c)(3) status or are otherwise out of compliance regain compliance with federal and state authorities.

Community Involvement

Ms. Singer regularly presents to students at local universities on startup topics. She is heavily involved with the Jonathan Nelson Center for Entrepreneurship at Brown University, and has also given presentations at Boston University, Suffolk Law School and Harvard Law School. Ms. Singer counsels students through Harvard's Innovation Lab.

Ms. Singer is also involved in Combined Jewish Philanthropies, through the Women's Division and the Lawyers' and Accountants' Division, as well as other community organizations including 100 Women of Needham and her children's schools.


Skip Navigation Links.


JD, cum laude, Harvard Law School, 2010, Editor-in-Chief, The Harvard Negotiation Law Review

AB, Cognitive Science and Judaic Studies, magna cum laude, Brown University, 2004, Phi Beta Kappa

Bar Admissions


Skip Navigation Links.